Cumulative sensitization and disease in a beryllium oxide ceramics worker cohort

Journal of Occupational and Environmental Medicine

Volumn 50, Issue 12, 2008, Pages 1343-1350

  Schuler, Christine R ^a   Kitt, Margaret M ^a   Henneberger, Paul K ^a   Deubner, David C ^b   Kreiss, Kathleen ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b Brush Wellman Inc North America   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BERYLLIUM; BERYLLIUM OXIDE;

BERYLLIOSIS; BLOOD SAMPLING; CERAMICS; COHORT ANALYSIS; CONFERENCE PAPER; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PREVALENCE; QUESTIONNAIRE; SENSITIZATION; WORKER; ADULT; AGED; ARTICLE; BLOOD; BRONCHOSCOPE; CHEMICAL INDUSTRY; CHRONIC DISEASE; HYPERSENSITIVITY; LYMPHOCYTE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; SMOKING;

ADULT; AGED; BERYLLIOSIS; BERYLLIUM; BRONCHOSCOPES; CERAMICS; CHEMICAL INDUSTRY; CHRONIC DISEASE; COHORT STUDIES; FEMALE; HUMANS; HYPERSENSITIVITY; INCIDENCE; LYMPHOCYTES; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; SMOKING;

EID: 65849150722     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e31818def24     Document Type: Conference Paper

References (27)

1. Kreiss K, Newman LS, Mroz MM, Campbell PA. Screening blood test identifies subclinical beryllium disease. J Occup Med. 1989;31:603-608.
2. Kreiss K, Mroz MM, Zhen B, Martyny JW, Newman LS. The epidemiology of beryllium sensitization and disease in nuclear workers. Am Rev Respir Dis. 1993;148:985-991.
3. Kreiss K, Wasserman SL, Mroz MM, Newman LS. Beryllium disease screening in the ceramics industry: blood lymphocyte test performance and exposuredisease relations. J Occup Med. 1993; 35:267-274.
4. 3. Am J Ind Med. 1996;30:16-25.
5. Kreiss K, Mroz M, Zhen B, Wiedemann H, Barna B. Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant. Occup Environ Med. 1997;54:605-612.
6. Deubner D, Kelsh M, Shum M, Maier L, Kent M, Lau E. Beryllium sensitization, chronic beryllium disease, and exposures at a beryllium mining and extraction facility. Appl Occup Environ Hyg. 2001; 16:579-592.
7. Henneberger PK, Cumro D, Deubner D, Kent M, McCawley M, Kreiss K. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant. Int Arch Occup Environ Health. 2001;74:167-176.
8. Rosenman K, Hertzberg V, Rice C, et al. Chronic beryllium disease and sensitization at a beryllium processing facility. Environ Health Perspect. 2005;113: 1366-1372.
9. Sackett HM, Maier LA, Silveira LJ, et al. Beryllium medical surveillance at a former nuclear weapons facility during cleanup operations. J Occup Environ Med. 2004;46:953-961.
10. Schuler CR, Kent MS, Deubner DC, et al. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility. Am J Ind Med. 2005;47: 195-205.
11. Stange AW, Hilmas DE, Furman FJ. Possible health risks from low exposure to beryllium. Toxicology. 1996;111:213-224.
12. Stange AW, Hilmas DE, Furman FJ, Gatliffe T. Beryllium sensitization and chronic beryllium disease at a former nuclear weapons facility. Appl Occup Environ Hyg. 2001;16:405-417.
13. Stanton ML, Henneberger PK, Kent MS, Deubner DC, Kreiss K, Schuler CR. Sensitization and chronic beryllium disease among workers in copper-beryllium distribution centers. J Occup Environ Med. 2006;48:204-211.
14. Welch L, Ringen K, Bingham E, et al. Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites. Am J Ind Med. 2004;46:207-218.
15. Newman LS, Mroz MM, Maier LA, Daniloff EM, Balkissoon R. Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant. J Occup Environ Med. 2001; 43:231-237.
16. Newman LS, Mroz MM, Balkissoon R, Maier LA. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk. Am J Respir Crit Care Med. 2005;171:54-60.
17. Frome EL, Newman LS, Cragle DL, Colyer SP, Wambach PF. Identification of an abnormal beryllium lymphocyte proliferation test. Toxicology. 2003;183: 39-56.
18. SAS Institute. SAS/STAT User's Guide. Version 9.1, Vols. 1-3. Cary, NC: SAS Institute; 2006.
19. Lindsey JC, Ryan LM. Tutorial in biostatistics methods for interval-censored data. Stat Med. 1998;17:219-238.
20. Cox DR, Oakes D. Analysis of Survival Data. New York: Chapman and Hall; 1984.
21. Deubner DC, Goodman M, Iannuzzi J. Variability, predictive value, and uses of the beryllium blood lymphocyte proliferation test (BLPT): preliminary analysis of the ongoing workforce survey. Appl Occup Environ Hyg. 2001;16:521-526.
22. Bobka CA, Stewart LA, Engelken GJ, Golitz LE, Newman LS. Comparison of in vivo and in vitro measures of beryllium sensitization. J Occup Environ Med. 1997;39:540-547.
23. Fontenot AP, Palmer BE, Sullivan AK, et al. Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response. J Clin Invest. 2005;115:2286-2893.
24. Stange AW, Furman FJ, Hilmas DE. The beryllium lymphocyte proliferation test: relevant issues in beryllium health surveillance. Am J Ind Med. 2004;46:453-462.
25. Cher DJ, Deubner DC, Kelsh MA, et al. Assessment of the beryllium lymphocyte proliferation test using statistical process control. Inhal Toxicol. 2006;18:901-910.
26. Deubner D, Kent M. Keeping beryllium workers safe: an enhanced preventive model. J Occup Environ Hyg. 2007;4: D23-D30.
27. Cummings KJ, Deubner DC, Day GA, et al. Enhanced preventive programme at a beryllium ceramics facility reduces beryllium sensitisation among new workers. Occup Environ Med. 2007;64:134-140.